Quick Answer
BIO KEY INTERNATIONAL INC reported R&D Expense of $2.51 million for fiscal year 2024.
BIO KEY INTERNATIONAL INC R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2024 | $2.51M | +4.9% |
| 2023 | $2.39M | -26.4% |
| 2022 | $3.25M | +38.1% |
| 2021 | $2.36M | +68.6% |
| 2020 | $1.40M | +4.9% |
| 2019 | $1.33M | -5.9% |
| 2018 | $1.42M | -14.7% |
| 2017 | $1.66M | -17.4% |
| 2016 | $2.01M | +29.1% |
| 2015 | $1.56M | -4.3% |
| 2014 | $1.63M | +21.0% |
| 2013 | $1.34M | +41.9% |
| 2012 | $947.4K | -15.2% |
| 2011 | $1.12M | +5.7% |
| 2010 | $1.06M | — |
Quarterly R&D Expense
| Quarter Ending | R&D Expense | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $683.6K | +4.8% | +7.5% |
| June 30, 2025 | $636.0K | +7.6% | +6.8% |
| March 31, 2025 | $595.8K | -1.9% | -8.6% |
| September 30, 2024 | $652.2K | +23.1% | +10.3% |
| June 30, 2024 | $591.2K | +5.9% | -2.7% |
| March 31, 2024 | $607.5K | -12.0% | +14.7% |
| September 30, 2023 | $529.8K | -36.1% | -5.1% |
| June 30, 2023 | $558.2K | -28.8% | -19.1% |
- BIO KEY INTERNATIONAL INC showed an increase of +4.9% in R&D Expense compared to the prior fiscal year.
- Over the 2010–2024 period, BIO KEY INTERNATIONAL INC’s r&d expense has grown by 137.8% (from $1.06 million to $2.51 million).
- The most recent figure is from BIO KEY INTERNATIONAL INC’s fiscal year 2024 report (Form 10-K), filed with the SEC on April 23, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: